Differentiated Thyroid Cancer with Brain Metastasis
Differentiated thyroid cancer is associated with favorable prognosis. The presence of distant metastases is generally rare. The most common sites of distant metastases are the lungs and bones followed by the brain and liver. Even with distant metastases, the 10-year survival can reach up to 50% in a majority of patients. However, the prognosis of patients with brain metastases generally differs and associates with cancer-associated mortality. In this chapter, the clinical progression and the diagnosis of brain metastases on follow-up are presented in a patient with papillary thyroid carcinoma.
KeywordsBrain metastases Thyroid cancer Progression Thyroglobulin
- 5.Haugen BR, Alexander EK, Bible KC, Doherty GM, Mandel SJ, Nikiforov YE, et al. American Thyroid Association management guidelines for adult patients with thyroid nodules and differentiated thyroid cancer: The American Thyroid Association guidelines task force on thyroid nodules and differentiated thyroid cancer. Thyroid. 2015;26:1–133.CrossRefGoogle Scholar
- 15.Akkas BE, Demirel BB, Vural GU. Prognostic factors affecting disease-specific survival in patients with recurrent and/or metastatic differentiated thyroid carcinoma detected by positron emission tomography/computed tomography. Thyroid. 2014;24:287–95. https://doi.org/10.1089/thy.2013.019.CrossRefPubMedGoogle Scholar
- 16.Vural GU, Akkas BE, Ercakmak N, Basu S, Alavi A. Prognostic significance of FDG PET/CT on the follow-up of patients of differentiated thyroid carcinoma with negative 131I whole-body scan and elevated thyroglobulin levels: correlation with clinical and histopathologic characteristics and long-term follow-up data. Clin Nucl Med. 2012;37:953–9. https://doi.org/10.1097/RLU.0b013e31825b2057.CrossRefPubMedPubMedCentralGoogle Scholar